United Kingdom-Bristol: HLA Typing for Immunogentics

Type of document: Contract Notice
Country: United Kingdom
Publication Ref: (2022/S 000-002592/EN)
Nature of contract: Supply contract
Procedure: Open procedure
Type of bid required: Global bid

Contract notice
Supplies

Section I: Contracting authority
I.1) Name and addresses
Official name: NHS Blood and Transplant
National registration number: NHS Blood and Transplant
Postal address: 500 North Bristol Park
Town: Bristol
Postal code: BS34 7QH
Country: United Kingdom
Contact Person: Jo Murphy
Telephone: +44 1179217218
Email: jo.murphy@nhsbt.nhs.uk
Internet address(es):
Main address:
Address of the buyer profile:

I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge,at:
Additional information can be obtained from:
the above mentioned address
Tenders or requests to participate must be submitted:
electronically via:
Electronic communication requires the use of tools and devices that are not generally available.
Unrestricted and full direct access to these tools and devices is possible,free of charge,at:
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health

Section II: Object
II.1) Scope of the procurement
II.1.1) Title: HLA Typing for Immunogentics

Reference number: C59291
II.1.2) Main CPV code: 33141625
II.1.3) Type of contract: Supplies
II.1.4) Short Description: HLA Typing for Immunogentics
II.1.5) Estimated total value:
Value excluding VAT: 1250000.00 Currency: GBP
II.1.6) Information about lots:
The contract is divided into lots: no
II.2) Description
II.2.3) Place of performance
Nuts code:
II.2.4) Description of the procurement:
HLA Typing for Immunogentics
II.2.5) Award criteria

II.2.6) Estimated value:
Value excluding VAT: 1250000.00 Currency: GBP
II.2.7) Duration of the contract,framework agreement or dynamic purchasing system
Duration in months: 36
This contract is subject to renewalyes Description of renewals:2 x 12 month extensions

II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:no

Section III: Legal, economic, financial and technical information
III.1) Conditions for participation

Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure:
Open procedure
IV.1.8) Information about the Government Procurement Agreement(GPA)
The procurement is covered by the Government Procurement Agreement: no
IV.2) Administrative information
IV.2.2) Time limit for receipt of tenders or requests to participate
Date: 2022-03-02
IV.2.4) Languages in which tenders or requests to participate may be submitted:EN
IV.2.6) Minimum time frame during which the tender must maintain the tender
Duration in months:6(from the date stated for receipt of tender)
IV.2.7) Conditions for opening tenders
Date: 2022-03-02 Local time: 12:00

Section VI: Complementary information
VI.1) Information about recurrence:
This is a recurrent procurement: yes
VI.2) Information about electronic workflows
VI.4) Procedures for review
VI.4.1) Review body
Official name: NHS Blood & Transplant, Barnsley
Postal address: Unit D, Capitol Way, South Yorkshire
Town: Barnsley
Postal code: S75 3FG
Country: United Kingdom
E-mail: purchasing@nhsbt.nhs.uk
Internet address:

VI.4.2) Body responsible for mediation procedures
Official name: NHS Blood & Transplant, Barnsley
Postal address: Unit D, Capitol Way, South Yorkshire
Town: Barnsley
Postal code: S75 3FG
Country: United Kingdom
E-mail: purchasing@nhsbt.nhs.uk
Internet address:
VI.4.4) Service from which information about the review procedure may be obtained
Official name: NHS Blood & Transplant, Barnsley
Postal address: Unit D, Capitol Way, South Yorkshire
Town: Barnsley
Postal code: S75 3FG
Country: United Kingdom
E-mail: purchasing@nhsbt.nhs.uk
Internet address:
VI.5) Date of dispatch of this notice:2022-01-28